Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.

ABSTRACT:

Background

A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting-enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied.

Methods

We carried out a population-based case-control study in the Lombardy region of Italy. A total of 6272 case patients in whom infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed between February 21 and March 11, 2020, were matched to 30,759 beneficiaries of the Regional Health Service (controls) according to sex, age, and municipality of residence. Information about the use of selected drugs and patients' clinical profiles was obtained from regional databases of health care use. Odds ratios and 95% confidence inter

SUBMITTER: Mancia G 

PROVIDER: S-EPMC7206933 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature